Effects of intranasal steroids on continuous positive airway pressure compliance among patients with obstructive sleep apnea
ConclusionThe addition of an intranasal steroid decreased the frequency of nasal symptoms, especially rhinorrhea and congestion, among patients with OSA initiating CPAP therapy and increased compliance to CPAP after 90 days of treatment.Trial registrationIRB approval ID: R179hClinical trial ID: TCTR20200715001
Source: Sleep and Breathing - Category: Respiratory Medicine Source Type: research
More News: Flonase | Obstructive Sleep Apnea | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study